Literature DB >> 1618275

Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea-pig ileum.

T Griesbacher1, F Lembeck.   

Abstract

The type of antagonism exhibited by three novel bradykinin (BK) antagonists, D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK (HOE 140, compound I), D-Arg-[Hyp3,D-Tic7,Oic8]BK (compound II) and [Arg(Tos)1,Hyp3,Thi5,D-Tic7,Oic8]BK (compound III), was compared with that of a conventional antagonist, D-Arg-[Hyp2,Thi5,8,D-Phe7]BK (compound IV), on the guinea-pig ileum. The novel compounds induced rightward displacements of cumulative concentration-response curves to BK, accompanied by a progressive reduction of the maximum effect (Emax) without a significant decrease in the slope, whereas no reduction of Emax was observed with compound IV. Actions of substance P on the guinea-pig ileum and of vasopressin on the rat uterus remained completely unaffected. It is concluded that as the novel BK analogues show competitive as well as non-competitive inhibition in the guinea-pig ileum, but the inhibition is reversible and specific, they are dual antagonists.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618275     DOI: 10.1016/0014-2999(92)90397-m

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.

Authors:  D G Sawutz; J M Salvino; R E Dolle; F Casiano; S J Ward; W T Houck; D M Faunce; B D Douty; E Baizman; M M Awad
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

2.  Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.

Authors:  M Félétou; M Germain; C Thurieau; J L Fauchère; E Canet
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

3.  In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.

Authors:  S Drube; C Liebmann
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Antagonism of kinin effects on epithelial by Hoe 140: apparently competitive and non-competitive interactions.

Authors:  A W Cuthbert; L J MacVinish; R J Pickles
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

5.  Kinin-induced relaxations of the rat duodenum.

Authors:  T Griesbacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

6.  Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats.

Authors:  C A Maggi; P Santicioli; E Del Bianco; A Lecci; S Guliani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

7.  Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.

Authors:  T Griesbacher; B Tiran; F Lembeck
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens.

Authors:  J Maas; G A Rae; J P Huidobro-Toro; J B Calixto
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Comparative study of endotoxin-induced hypotension in kininogen-deficient rats with that in normal rats.

Authors:  A Ueno; H Ishida; S Oh-ishi
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.